In conclusion, our result demonstrated that Nna1 mutation in AMS mice might alter NNA1 function, leading to increased β-tubulin glutamylation and stability as well as decreased MAP2 expression. This evidence concerns the gene AGTPBP1 and ablepharon macrostomia syndrome.